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Glycoprotein 130 (gp130) is the signal transducing receptor subunit for cytokines of the interleukin-6 (IL-6) family, and it is expressed in
a multitude of cell types of the immune and nervous system. IL-6-like cytokines are not only key regulators of innate immunity and
inflammation but are also essential factors for the differentiation and development of the somatosensory system. Mice with a null
mutation of gp130 in primary nociceptive afferents (SNS-gp130/) are largely protected from hypersensitivity tomechanical stimuli in
mouse models of pathological pain. Therefore, we set out to investigate how neuronal gp130 regulates mechanonociception. SNS-
gp130/mice revealed reducedmechanosensitivity to highmechanical forces in the von Frey assay in vivo, and this was associatedwith
a reduced sensitivity of nociceptive primary afferents in vitro. Together with these findings, transient receptor potential ankyrin 1
(TRPA1) mRNA expression was significantly reduced in DRG from SNS-gp130/mice. This was also reflected by a reduced number of
neurons responding with calcium transients to TRPA1 agonists in primary DRG cultures. Downregulation of Trpa1 expression was
predominantly discovered in nonpeptidergic neurons, with the deficit becoming evident during stages of early postnatal development.
Regulation of Trpa1 mRNA expression levels downstream of gp130 involved the classical Janus kinase family-signal transducer and
activator of transcription pathway. Our results closely link proinflammatory cytokines to the expression of TRPA1, both of which have
been shown to contribute to hypersensitive pain states. We suggest that gp130 has an essential role in mechanonociception and in the
regulation of TRPA1 expression.
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Introduction
Neuropoietic cytokines of the interleukin-6 (IL-6) family are es-
sential regulators of innate immunity and nerve regeneration.
The cytokines act on their target cells via heteromeric receptor
complexes that require glycoprotein 130 (gp130) as signal trans-
ducer subunit (Heinrich et al., 2003). In addition to IL-6, the
family consists of IL-11, IL-27, leukemia inhibitory factor (LIF),
ciliary neurotrophic factor (CNTF), oncostatin M (OSM), neu-
ropoietin, cardiotrophin-1, and cardiotrophin-like cytokine
(Bauer et al., 2007).
In addition to their role in innate immunity, gp130-targeting
cytokines are important survival and differentiation factors. IL-6,
CNTF, OSM, and LIF play crucial roles in the brain and in the
peripheral nervous system (Murphy et al., 1991, 1993; Thompson
et al., 1996; Banner et al., 1998; Nakashima et al., 1999; Zhong et
al., 1999). OSM, for example, is essential for the development and
survival of a subpopulation of TRPV1/P2X3-positive sensory
neurons (Morikawa et al., 2004). However, OSM and IL-6, but
not LIF, sensitize nociceptors to heat (Langeslag et al., 2011).
Thermal sensitization occurs as a consequence of fast modu-
lation of the heat and capsaicin-sensitive ion-channel TRPV1,
whereas ablation of gp130 in Nav1.8-expressing small-diameter
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DRG neurons (SNS-gp130/) reduces thermal hypersensitivity
in models of pathological pain (Obreja et al., 2002, 2005; And-
ratsch et al., 2009). Furthermore, IL-6 sensitizes nociceptors to
noxious mechanical stimuli, and SNS-gp130/mice are largely
protected and recover faster frommechanical hypersensitivity in
models of inflammatory, neuropathic, and cancer pain (Brenn et
al., 2007; Quarta et al., 2011).
It is generally accepted that the detection of noxious mechan-
ical stimuli (mechanonociception) relies on the presence of
mechanically activated ion channels in nociceptive neurons. Dif-
ferential expression and sensitization of these putative ion chan-
nels very likely contribute to the mechanical hypersensitivity
associated with chronic pain states. Despite the anticipated im-
portance of such channels, the cellular and molecular mecha-
nisms of mechanonociception are still incompletely understood
(Lumpkin and Caterina, 2007; Dubin and Patapoutian, 2010;
Delmas and Coste, 2013).
In the present study, we assessed mechanonociception in the
SNS-gp130/ mouse model in vivo and with an in vitro skin-
nerve preparation. Moreover, a genome-wide mRNA expression
profiling assay was used to screen for differential expression of
nociceptor-specific ion-channel mRNA. The expression of can-
didates was assessed with quantitative TaqMan RT-PCR, ISH of
DRG sections, as well as correlative functional assays. Here, we
demonstrate that ablation of gp130 reduces the sensitivity of no-
ciceptive fibers to noxious mechanical stimuli and that the pres-
ence of gp130 in small DRG neurons is essential for the
expression of the TRPA1 ion channel.
Materials andMethods
Animals. SNS-gp130/ and gp130fl/fl mice were generated, bred, and
genotyped as described previously (Andratsch et al., 2009). Briefly,
gp130fl/fl mice were cross-bred with SNS-Cremice (Agarwal et al., 2004)
to obtain SNS-Cre-gp130fl/fl (SNS-gp130/) and gp130fl/flmice. Allmice
were maintained under specific pathogen free conditions. TRPA1/
mice were a generous gift from Dr. David Corey (Harvard Medical
School, Boston) and used as controls where appropriate (Kwan et al.,
2006). Unless otherwise stated, animals of either sex and older than 8
weeks were used in all experiments. For postnatal development studies,
animals were staged by their date of birth. Day of birth was counted as
postnatal day 0 (P0). Behavioral measurements and analyses were per-
formed in awake, unrestrained, age-matched, male mice with an age of
8–16 weeks by examiners who were blinded to the genotype of the mice.
All animal procedures were in accordance with ethical guidelines and
animal welfare regulations according to Austrian law and with formal
permission of the Austrian BMWF ministry (BMWF-66.011/0051-II/
10b/2008; BMWF-66.011/0113-II/3b/2010).
Mechanical sensitivity. Mice were placed in a plastic chamber with a
wire mesh floor and allowed to habituate for 1 h before starting the test.
The lateral side of the plantar surface of the paw (sural nerve innervation
territory) was stimulated by calibrated von Frey monofilaments. Fila-
ments were applied in an ascending force order (1.4, 4, 8, 16, 22.6, 32, and
45.3 mN), and the frequency of paw withdrawal to 5 stimuli for each
monofilament was recorded. The threshold was taken as the lowest force
that evoked a brisk withdrawal response to two of five repetitive stimuli.
Mechanical sensitivity was assessed on two separate days, and threshold
valueswere averaged per animal. One animal in the SNS-gp130/ group
failed to fulfill the threshold criterion and was assigned the highest me-
chanical force (45.3 mN) as threshold.
Nocifensive behavior. Spontaneous pain-like behavior was monitored
after intracutaneous injection of 20 l of 1% cinnamaldehyde (CA,
Sigma) or vehicle (20% Tween 80, Sigma) in PBS (PAA) into the hind-
paw of gp130fl/fl or SNS-gp130/ mice. Mice were placed in a plastic
chamber and allowed to habituate for at least 1 h before the experiment.
Movies were taken with a Zx1 (Kodak) or an IN-3011 (Instar) camera
through the translucent floor of the box so that the hindpawswere visible
at all times. Behavioral responses were scored for 5 min after injection.
Vehicle controls were injected into the hindpaw contralateral to CA 1
week after the initial treatment, and the mice did not show a response
during the analyzed time frame.
Single fiber recordings. An in vitro skin nerve preparation was used to
investigate the properties of unmyelinated afferent nerve fibers innervat-
ing the skin of the mouse dorsal hindpaw as previously reported (And-
ratsch et al., 2009; Quarta et al., 2011). The saphenous nerve was
dissectedwith the skin of the dorsal hindpaw attached andmounted in an
organ bath “inside-up” to expose the corium side. The preparation was
superfused (15 ml/min) with an oxygen-saturated modified synthetic
interstitial fluid solution containing (in mM) as follows: 108 NaCl, 3.48
KCl, 3.5 MgSO4, 26 NaHCO3, 1.7 NaH2PO4, 2.0 CaCl2, 9.6 sodium glu-
conate, 5.5 glucose, and 7.6 sucrose at a temperature of 31 1°C and pH
7.4 0.05. The saphenous nerve was pulled into a separate chamber of
the organ bath and placed on a small mirror. Using sharpened watch-
makers’ forceps, fine filaments were teased from the desheathed nerve
and placed on a gold wire recording electrode. Action potentials of
single-nerve strands were recorded extracellularly, amplified (5000),
filtered (low pass 1 kHz, high pass 100Hz), visualized on an oscilloscope,
and stored on a PC-type computer with Spike/Spidi software package for
offline analysis using a template-matching procedure. The fibers were
characterized as unmyelinated (C) according to their conduction veloc-
ity (2 m/s, calculated from the latency of unitary action potential to
electrical stimulus at receptive field and distance of receptive field to
recording electrode) and on the basis of the shape of the action potential.
The receptive field of the primary afferent fiber was located by mechan-
ical probing of the skin with a blunt glass rod. Only units with a signal-
to-noise ratio2 were used for further analysis. Fibers were subject to a
standard protocol of adequate mechanical stimuli. The mechanical
threshold of each unit was determined with a set of calibrated von Frey
monofilaments with uniform tip diameter 1.1 mm and bending forces
ranging from1 to 362mN.The strength of the finest filament that evoked
at least 3 action potentials was defined as activation threshold.
DRG culture.DRG containing the cell bodies of primary afferents were
harvested from adult mice as previously published (Andratsch et al.,
2009; Camprubí-Robles et al., 2013). After removal of the connective
tissue, ganglia were incubated in Liberase Blendzyme 1 (9 mg/100 ml
DMEM,Roche) for 2 times at 30min. After washingwith PBS (PAA), 1
trypsin-EDTA (Invitrogen)was added for 15min, andDRGwerewashed
three times with DMEM and once with TNB medium (Biochrom) sup-
plemented with Protein-Lipid-Complex (Biochrom), L-glutamine, pen-
icillin G sodium, and streptomycin sulfate (all from Invitrogen). The
DRG were dissociated in TNB medium with a fire-polished Pasteur pi-
pette and centrifuged through a 3.5% BSA gradient (Sigma) to eliminate
non-neuronal cells and debris. The sensory neurons were resuspended,
plated on either 6-well or 24-well culture dishes (Nunc) coated with
poly-L-lysine/laminin-1 (Sigma), and cultivated in supplementedTNB at
37°C in 5% CO2 for 24 h, unless otherwise indicated. For microfluori-
metric calcium measurements, cells were plated on glass-bottom dishes
coated with poly-L-lysine/laminin-1 (Sigma) and cultivated for 18–32 h.
Exogenous mNGF 2.5S (Alomone Labs, 10 g/ 100 ml TNB medium)
was added whenever indicated.
In vitro inhibitor studies.DRGwere harvested from spinal segments T1
toL6, andcultureswerepreparedasdescribedabove.Dissociatedneuronsof
one to three gp130fl/flmice were pooled and subsequently divided into con-
trol and inhibitor samples. Inhibitor sampleswere first pretreatedwith non-
toxic concentrations of Janus kinase family (JAK) inhibitor I (1 M,
Calbiochem/Millipore) (Loy et al., 2011) or signal transducer and activator
of transcription (STAT) inhibitor Stattic (1.5M, Sigma) (S. Quarta, Medi-
cal University Innsbruck, Austria, personal communication) in TNB me-
dium for 1 h and then incubated with the same concentration of inhibitor
diluted in TNBmedium containing exogenousmNGF 2.5S for 72 h. Inhib-
itors were dissolved inDMSO in amaximal final dilution of 1:1000. Control
samples received an equal treatmentwithmedium containing the appropri-
ate concentration of vehicle.
Genome-wide mRNA expression profiling assay. DRG explants were
prepared as described above. DRG samples of two littermate mice were
always pooled, and a total of 10 gp130fl/fl and 10 SNS-gp130/ mice
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were divided into five groups per genotype. RNA isolation, cRNA prep-
aration, and microarray measurement with subsequent analysis were
performed by IMGM Laboratories using Mouse Genome Survey Mi-
croarray V2.0 with the 1700 Chemiluminescent Microarray Analyzer
(Applied Biosystems). For genes to be included in the analysis, all five
samples of at least one genotype had to obtain a signal-to-noise ratio of
3. Functional annotation of the genes was based on the Panther2.0
database (www.pantherdb.org). All genes that belonged to the Panther-
_Function “ion channel” or “ligand-gated ion channel” were grouped as
“ion channels.” Only genes with net fold changes1.5 were considered
as differentially expressed between the two genotypes. Student’s t test was
applied to compare SNS-gp130/ and gp130fl/fl groups. The p values
were corrected for multiple testing using the algorithm of Benjamini and
Hochberg, which is based on a control of the false discovery rate (FDR)
(Benjamini and Hochberg, 1995). Microarray data are available in the
ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession
number E-MTAB-2584.
qRT-PCR. For analysis of mRNA expression levels, total RNA was
isolated frommurineDRG explants or primary cultures of DRGneurons
by using TRI Reagent (Sigma) or peqGOLD TriFast (PeqLab) as previ-
ously published (Andratsch et al., 2009). DRG explants were lysed with a
Tissue Lyser II (QIAGEN) or manually using plastic pestles. Primary
cultures of DRG neurons were directly lysed on the culture dish and
subsequently used for RNA extraction. The quantity of RNA was ana-
lyzed using a BioPhotometer (Eppendorf) or a Nanodrop 2000 (Thermo
Scientific) and, where applicable, RNA quality was verified by gel elec-
trophoresis. Reverse transcription to cDNA was performed using MuLv
reverse transcriptase (2.5 U/l, Applied Biosystems) with random
hexamer primers (10 ng/l), RiboLock (2 U/l), 1 Taq Buffer (all
from Thermo Scientific), MgCl2 (5 mM), and dNTPs (1 mM, both
Fermentas). cDNA samples were analyzed for expression of target
genes by quantitative real-time TaqMan PCR using TaqMan 5 nu-
clease assays (all from Applied Biosystems). With the exception of 18S
(18S ribosomal RNA, Hs99999901_s1), the following exon spanning
assays were used: Mm01352363_m1 (succinate dehydrogenase sub-
unit A, Sdha), Mm00625268_m1 (transient receptor potential
ankyrin 1, Trpa1), Mm01246302_m1 (transient receptor potential va-
nilloid 1, Trpv1), Mm00499025_m1 (transient receptor potential vanil-
loid 4, Trpv4 ), and Mm99999915_g1 (glyceraldehyde-3-phosphate
dehydrogenase, Gapdh). Reactions were performed in a MicroAmp Fast
Optical 96-Well Reaction Plate (Applied Biosystems) using the 7500 Fast
Real-Time PCR System (Applied Biosystems) for thermal cycling and
real-time fluorescence measurements. The PCR cycle protocol consisted
of 10min at 95°C, and 50 two-step cycles of 15 s each at 95°C and of 1min
at 60°. Positive and negative controls (no-template controls for RNA
extraction, RT-PCR, and TaqMan-qPCR) were included in the experi-
ments. Each sample was run in duplicates or triplicates. Threshold cycle
(CT) values were recorded as ameasure of initial template concentration.
For duplicates, only samples with a CT value range0.5 for the replicates
were included in the analysis. Exceptions were made for Trpa1 expres-
sion in DRG explants during postnatal days 1 and 2 because of the low
expression of TRPA1. Relative fold changes in mRNA levels were calcu-
lated by the		CTmethod using Sdha as a reference standard. The range
for the target gene relative to gp130fl/fl samples as calibrator was calcu-
lated by 2		CT.
ISH: probes. A region complementary to base pairs 957–1761 of mu-
rineTrpa1mRNA(NM_177781.4)was amplified from full-length cDNA
by PCR. Specifically designed primer pairs introduced T7 (antisense
probe: 5-TAATACGACTCACTATAGGGGTTCAGGAGGATGTCAG-
CATTG-3) and SP6 (sense probe; 5-CATACGATTTAGGTGACAC-
TATAGGAGACCCTGCTTCACAGAG-3) RNA polymerase promoter
regions at the 5ends of the amplified region. Amplified DNA fragments
were visualized by gel electrophoresis and purified by gel extraction using
the MinElute Gel Extraction Kit (QIAGEN). Digoxigenin-labeled cRNA
was synthesized by in vitro transcription using theDIGRNALabeling Kit
(SP6/T7) according to the manufacturer’s instructions (Roche).
Tissue preparation. LumbarDRGs (L1-L6) were harvested, fixed in 4%
PFA (Fluka/Sigma) for 3–4 h at room temperature, washed three times in
1 PBS for 10–30 min, and cryoprotected in 25% sucrose (Merck)/PBS
overnight at 4°C. Tissue samples were embedded in Tissue-Tek OCT
Compound (Sakura), snap-frozen in liquid nitrogen, and kept at80°C
until use.
Cryostat sections (12 m) were mounted on Super Frost Plus slides
(Thermo Scientific), air-dried for 1–3 h at room temperature, fixed with
4%PFA for 30min, and prehybridizedwith equilibration buffer contain-
ing the following: 12.6 mM Tris (Roth) at pH 7.5, 185 mM NaCl (Sigma),
10 mM NaH2PO4 (Merck), 5 mM EDTA (Sigma), 50% deionized forma-
mide (Sigma), 0.5Denhardt’s (Sigma) in DEPC-treated H2O for 5–15
min at room temperature. Hybridization was performed overnight at
68°C in a humidified chamber. cRNAprobes were diluted 1:50 in hybrid-
ization buffer containing 12.6 mM Tris (Roth), pH 7.5, 185 mM NaCl
(Sigma), 10mMNaH2PO4 (Merck), 5mMEDTA (Sigma), 50%deionized
formamide (Sigma), 10% dextrane sulfate (Sigma), 1 mg/ml yeast RNA
(Roche), and 0.5 Denhardt’s (Sigma) in DEPC-treated H2O. Sections
were then washed two times for 30 min at 68°C in 1 SSC (Sigma), pH
7.0, 25% formamide, 0.1% Tween 20 (Sigma), twice for 30min and once
for 1 h at room temperature in 100 mM maleic acid (Sigma), 150 mM
NaCl (Sigma), and 0.1% Tween 20 (Sigma), pH 7.5 (MABT). Sections
were blocked for 1 h at room temperature with 20% FBS (Biochrom)
in MABT before overnight incubation with alkaline phosphatase-
conjugated anti-digoxigenin antibody (Roche; 1:3000) diluted in 20%
FBS/MABT. Sections were washed 3 20min inMABT at room temper-
ature and twice 10 min with alkaline phosphatase buffer containing 100
mM Tris, pH 9.5, 50 mM MgCl2 (Merck), 100 mM NaCl, 0.1% Tween 20,
and 0.024% levamisol (Fluka/Sigma). Revelation was performed using
NBT/BCIP (Roche) in alkaline phosphatase buffer for 22–26 h at room
temperature in the dark. The reactionwas stopped by 2washeswith 5mM
EDTA/PBS, before postfixation with 4% PFA for 30 min at room tem-
perature and subsequent embedding in Mowiol (Calbiochem).
For FISH, the same protocol was applied for hybridization and subse-
quent washing and blocking steps. Sections were incubated with alkaline
phosphatase-conjugated anti-digoxigenin antibody (Roche; 1:1000),
and revelation was performed using 2-hydroxy-3-naphtoic acid-2-
phenylanilide phosphate (HNPP)/Fast Red (Roche). Briefly, sections
were incubated with a freshly prepared solution of 0.1 mg/ml HNPP and
0.25 mg/ml Fast Red TR for 30 min at room temperature and then
washed in alkaline phosphatase buffer (without levamisol). This proce-
dure was repeated three times. Afterward, sections were washed once in
PBS and stained with isolectin B4 (IB4)-Alexa-488 (1:200, Invitrogen) in
PBS for 30 min at room temperature before embedding in Mowiol. For
comparisons between genotypes, sections from equal numbers of ani-
mals per genotype (gp130fl/fl or SNS-gp130/) were placed on one slide
and therefore subject to the same treatment. Sections of four to six DRG
were used per animal.
Pictures were taken through an Axiovert 200M (Zeiss) with aNeofluar
40 oil-immersion objective. NBT/BCIP-stained sections were illumi-
nated using the bright field modus with a constant light intensity and 50
ms exposure time. Staining intensity was measured as mean gray value
per neuron. Per section, gray values of one nonstained neuron were
measured as background control. Because gray values correlated in-
verselywith staining intensities, neuronswith staining intensities exceed-
ing background by 3.5 times the SD were considered as Trpa1-positive.
Sections incubated with sense probe served as negative control and did
not reveal any specific staining. HNPP/Fast Red TR staining was visual-
ized using a matching filter set (BP 546/10, Omega; FT 560, BP 575–640,
Zeiss) with 300 or 500ms exposure time. All pictures were normalized to
500ms exposure time and a thresholdwas applied to discriminateTrpa1-
positive neurons. Sections hybridized with sense cRNA probes served as
negative control and yielded 4% of positive neurons with the applied
threshold. Approximately 300–1000 neurons per animals were analyzed,
and data are displayed as means per animal. Quantification was per-
formed using ImageJ (National Institutes of Health) (Schneider et al.,
2012). All analyses were performed by an examiner who was blinded to
genotype and sense/antisense staining.
Microfluorimetric calciummeasurements.Twenty-four hourDRGneu-
ron cultures were incubated with 6 M calcium (Ca2)-sensitive dye
fura-2 AM (Invitrogen) in TNBmedium (Biochrom) for 30 min at 37°C
in 5%CO2 in a humidified incubator. Then cells werewashed and kept in
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extracellular solution containing the following
(inmM): 145NaCl, 5 KCl, 2 CaCl2, 1MgCl2, 10
D-glucose (all from Merck) and 10 HEPES
(Roth), at pH 7.3 adjusted with NaOH
(Merck). Ratiomeric measurements were per-
formed using a Zeiss Axiovert 200 microscope
(Zeiss) with a Fluor 20/0.75 NA objective
(Zeiss). Fura-2was excited consecutively at 340
and 380 nm (excitation time: 55 ms) with a
polychrome IVmonochromator (TILL Photo-
nics), and fluorescence intensities were filtered
by a 510 nm long pass filter and recorded with
a CCD camera (Roper Scientific) at 1 s inter-
vals. For data acquisition, MetaFluor 7.1.2.0
(Molecular Devices) was used, and off-line
analysis was performed with Excel 2007 (Mi-
crosoft). Data traces were filtered by a simple
3-pointmoving average. All chemicals were di-
luted in extracellular solution and applied by a
gravity-driven perfusion system (Dittert et al.,
1998). Only cells with a low and stable baseline
Ca2 signal within the first 120 s of the proto-
col were used for analysis. The inclusion crite-
rion for cells responsive to CA or capsaicin was
set to 125% of the baseline Ca2 signal 10 s
before stimulation. The threshold for a positive
response to 5-nitro-2-(3-phenylpropylamino)
benzoic acid (NPPB) was defined by the highest
Ca2 signal in TRPA1/DRG neurons during
stimulation. Viability of the neurons was tested
with a 10 s pulse of 25 mM potassium chloride
solution in each experiment. All chemicals were
purchased from Sigma.
Statistical analysis. Statistical analysis was
performed per animal (N), and per nerve fiber
or number of cells (n) for the single-nerve fiber
recording and calcium imaging data. For statis-
tical analysis, Sigma Stat 3 and Origin Pro 8
software were used, and the data are presented
as mean  SEM unless otherwise indicated. Depending on sample size,
distribution, and number of variables, one-wayANOVAwith post Tukey
test, unpaired Student’s t test, two-way ANOVA, or the nonparametric
Mann–WhitneyU test for comparison between groups, and  2 test with
Yates correction as well as Kolmogorov–Smirnov test were used as stated
in the respective text. Differences were considered statistically significant
at p 0.05.
Results
Reducedmechanonociception in SNS-gp130/mice
Because IL-6 sensitizes nociceptors to mechanical stimuli and its
receptor gp130 is required for the maintenance of mechanical
hypersensitivity in several rodent models of pathological pain
(Brenn et al., 2007; Quarta et al., 2011), we hypothesized that
gp130 may be an important switch for the function of mecha-
nonociceptors. Therefore, we assessed the reflex withdrawal
thresholds to mechanical stimuli of increasing strength of
gp130fl/fl and SNS-gp130/mice with a calibrated set of von Frey
filaments. Response frequencies of SNS-gp130/mice were sig-
nificantly lower than those of gp130fl/fl mice (two-way ANOVA:
genotype: F(1,125) 
 38.99051; p  0.00001, force: F(6,125) 

40.08017; p 0.00001, genotype force: F(6,125)
 1.91561, p

0.08432;N
 9; Fig. 1A), and the medianmechanical withdrawal
threshold was significantly higher for SNS-gp130/ than for
gp130fl/flmice (gp130fl/fl: 16 mNwith 8 mN and 19.3 mN as lower
and upper quartile vs SNS-gp130/: 27.3 mN with 24 mN and
30.65 mN as lower and upper quartile; Mann–Whitney U test,
T
 54, p
 0.00619;N
 9; Fig. 1B). Both parameters indicated
that SNS-gp130/ mice were less sensitive to mechanical stim-
ulation than control mice. Because the deletion of gp130 was
restricted to Nav1.8-expressing unmyelinated sensory neurons,
we analyzed the mechanical thresholds of C-fibers in SNS-
gp130/ mice using single-nerve fiber recordings in a skin-
saphenous nerve in vitro preparation. Mechanical probing of the
receptive field with von Frey filaments revealed that the mechan-
ical activation thresholds of C-mechano- and polymodal nocice-
ptors were shifted to stronger forces in SNS-gp130/ mice
(activation threshold: gp130fl/fl: median: 32 mN with 22.6 mN
and 109 mN as lower and upper quartile vs SNS-gp130/: me-
dian: 128 mN with 27.3 mN and 181 mN lower and upper quar-
tile, Mann–Whitney U test, T 
 2065.5, p 
 0.01369; Fig. 1C),
suggesting that nociceptors were less sensitive to mechanical
stimulation in SNS-gp130/mice comparedwith gp130fl/flmice.
In accordance with the behavioral experiments, the greatest dif-
ferences were observed in the medium to high force range with
the maximal accumulated difference at 32 mN (gp130fl/fl vs
SNS-gp130/, Kolmogorov–Smirnov Test, D: 0.32381, p 

0.01219; Fig. 1D).
Reduced expression of Trpa1mRNA in SNS-gp130/DRG
neurons
gp130 signaling regulates mRNA expression in target cells classi-
cally via the JAK-STAT or via alternative pathways (Heinrich et
al., 2003). A commercial genome-wide mRNA expression screen
was used to compare expression levels of ion channels between
gp130fl/fl and SNS-gp130/ DRG explants. Out of the 177 ana-
Figure 1. SNS-gp130/mice were less sensitive to mechanical stimulation. A, SNS-gp130/mice responded with signif-
icantly lower frequencies to mechanical stimulation with von Frey hairs than control gp130fl/fl mice (N
 9, two-way ANOVA,
genotype: p 0.001, forces: p 0.001, genotype forces: p
 0.084). B, Stimulus–response relationship of SNS-gp130/
mice in the von Frey test was shifted toward stronger forces as SNS-gp130/ mice exhibited significantly higher mechanical
thresholds than gp130fl/flmice. Boxes representmedian aswell as lower and upper quartile; whiskers represent the 10th and 90th
percentiles.C, In vitro, the distribution ofmechanical thresholdswas significantly shifted toward stronger stimuli for unmyelinated
mechanosensitive afferents obtained from SNS-gp130/ (black columns) compared with those from gp130fl/fl mice (white
columns; gp130fl/fl: median: 32 mN, n 
 63, N 
 30; black columns: SNS-gp130/: median: 128 mN, n 
 35, N 
 23;
Mann–WhitneyU test, p 0.05).D, The cumulative distribution showed that a significantly lower percentage of fibers responded
to medium to high mechanical forces in SNS-gp130/mice. *p 0.05. **p 0.01.
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lyzed genes, 5 candidates were at least 1.5-fold upregulated, and 4
candidates demonstrated a 1.5-fold (or higher) downregulation
in SNS-gp130/ mice (Fig. 2A,B). Within the group of ion
channels with a putative mechanosensitive function, the screen
detected 14 of 17 possible targets, but only Trpa1mRNA expres-
sion levels were 1.5-fold lower in DRG explants of SNS-
gp130/ mice compared with gp130fl/fl mice (Fig. 2C; Table 1).
Because the deregulation of Trpa1mRNA between gp130fl/fl and
SNS-gp130/ mice revealed a relatively high FDR-adjusted p
value, we confirmed this result by quantifying Trpa1 mRNA
levels in thoracic and lumbar DRG explants of gp130fl/fl and
SNS-gp130/mice with TaqMan qRT-PCR. Explants of SNS-
gp130/ mice expressed significantly less Trpa1 mRNA than
gp130fl/fl mice (gp130fl/fl: 1.03 0.13 vs SNS-gp130/: 0.38
0.05, N 
 5–7; Mann–Whitney U test, T 
 50, p 
 0.00253;
Fig. 3A). Furthermore, we assessed the Trpa1mRNA expression
levels in primary neuron cultures of SNS-gp130/ and gp130fl/fl
DRG. Trpa1 expression levels were three times lower in neuron
cultures of SNS-gp130/ compared with gp130fl/fl mice (gp130fl/fl:
1.00  0.04 vs SNS-gp130/: 0.32  0.06, N 
 3–5; Mann–
WhitneyU test, T
 21, p
 0.0357; Fig. 3B). In contrast, expres-
Table 1. Genome-widemRNA expression screen of mechanotransducer ion channel
candidates
Gene symbol
Linearized fold change: SNS-gp130/
versus gp130 fl/fl Net fold change1.5
Trpa1 2.8538 
Trpv2 1.1479 
P2rx3 1.1412 
Kcna2 1.1381 
Asic2 1.0220 
Piezo1 1.0216 
Asic3 1.0137 
Trpc1 1.0033 
Trpc3 1.0173 
Piezo2 1.0765 
Trpc6 1.1097 
Trek-1 1.1177 
Traak 1.1525 
Kcna1 1.2410 
Asic1 Not detectable 
Kcnq4 Not detectable 
Trpv4 Not detectable 
Figure 2. Genome-wide mRNA expression profiling assay. A, Average ion channel expression intensities in SNS-gp130/ compared with gp130fl/fl DRG explants (N
 5). Depicted are the
means of the quantile-normalized signals. The linear values are shown in a log2 scaling. FDR-adjusted p values for deregulated genes: Scn5a, p
 0.162797384; Kcnh1, p
 0.309818818; Chrnb4,
p
 0.112616368; Kcnj11, p
 0.36698117; Scn3b, p
 0.396426446; Trpc7, p
 0.378056322; Cacna1f, p
 0.5246788; Trpa1, p
 0.363034703; LOC637107, p
 0.31986923. B, Heat map
showing ion channel gene expression in SNS-gp130/ versusgp130fl/flDRGexplants. Genes,which are upregulated (green, left) or downregulated (magenta, right), are sortedby their unadjusted
p value. Only geneswith p 0.05 are shown. C, Expressed ion channels with a putative function inmechanotransduction. Expression levels are shown as log2 quantile-normalized signal values for
each candidate and genotype (open circles represent gp130fl/fl; filled circles represent SNS-gp130/), and variation between individuals is minimal. Among the 14 genes, Trpa1 is the only
deregulated ion channel. For fold change in expression levels, see Table 1.
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sion levels of Trpv1 and Trpv4, two
members of the TRP superfamily of ion
channels expressed in nociceptive neu-
rons, were unaltered in DRG explants of
SNS-gp130/ mice (Fig. 3B). This sug-
gests that gp130 deletion specifically tar-
getsTrpa1 expression, whereas expression
of other ion channels of the TRP family,
which substantially contribute to hyper-
nociception in mouse models of patho-
logical pain, is not regulated by gp130 (for
review, see Dubin and Patapoutian,
2010). Moreover, OSM knock-out mice
reveal a reduced response in the formalin
test, which largely depends on TRPA1
(Morikawa et al., 2004; McNamara et al.,
2007). Last, to rule out an unspecific effect
of the Cre-recombinase on Trpa1 mRNA
expression, we assessed Trpa1 mRNA ex-
pression levels in lumbar DRG explants of
SNS-Cremice.Trpa1 expressionwas similar
for gp130fl/fl and SNS-Cremice, in contrast
to SNS-gp130/ mice, which expressed
significantly less Trpa1 mRNA than both
control strains (gp130fl/fl: 1.02  0.08 vs
SNS-Cre: 0.87  0.07 vs SNS-gp130/:
0.51 0.03, N
 7 or 8; one-way ANOVA
F(2,22) 
 15.96582, p 
 0.00007; Tukey
post test gp130fl/fl vs SNS-Cre p
 0.21981,
gp130fl/fl vs SNS-gp130/ p 
 0.00019,
SNS-Cre vs SNS-gp130/ p 
 0.00269;
Fig. 3B).
Functional recombination and dele-
tion of gp130 in Nav1.8-Cre mice start at
the day of birth (P0), nearly coinciding
with the occurrence of Trpa1 expression
(Agarwal et al., 2004; Hjerling-Leffler et
al., 2007). We therefore assessed whether
the deficit inTrpa1 expressionwas already
present during this early postnatal period.
In DRG of SNS-gp130/ and control
mice, Trpa1 mRNA expression started to
be detectable within the first postnatal
week. In control mice, Trpa1 mRNA ex-
pression increased to 42.9% of the adult
expression, at up to postnatal day P14. However, in SNS-
gp130/ DRG, Trpa1 mRNA was low from P0 and remained
significantly reduced at postnatal days P7 and P14 (gp130fl/fl vs
SNS-gp130/: P1  2: 0.023  0.002 vs 0.011  0.000, T 
 6,
p 
 0.01273; P7: 0.191  0.011 vs 0.095  0.007, T 
 21, p 

0.00179; P14: 0.429  0.024 vs 0.167  0.009, T 
 84, p 

0.00031, all Mann–WhitneyU test; Fig. 3C). These results indeed
suggest that gp130 acts as a switch for Trpa1 expression and the
postnatal development of the nociceptive system.
Deregulation of Trpa1mRNA expression in nonpeptidergic
neurons of SNS-gp130/mice
DRG contain all populations of sensory neurons, which can be
defined by their function (e.g., as mechanonociceptors of the
C-fiber class) and by certain immunohistochemical markers that
are associated with certain neuron types. Even nociceptive pri-
mary afferents represent heterogeneous neuronal subpopula-
tions. These can be primarily divided into peptidergic neurons,
expressing the neuropeptides substance P or calcitonin gene-
related peptide, and nonpeptidergic neurons, which bind IB4. At
the same time, the differential expression of specific receptor
molecules determines the function of the nociceptor subpopula-
tions (for review, seeDubin and Patapoutian, 2010). Therefore, it
was important to identify the DRG subpopulation that requires
gp130 for Trpa1 expression. We used nonradioactive ISH to as-
sess and localize Trpa1 mRNA expression in subpopulations of
lumbar DRG (L1-L6) of SNS-gp130/ and control mice. First,
chromogenic ISH with NBT/BCIP was used to determine ribo-
probe specificity and general Trpa1 mRNA expression. In con-
trast to the sense probe, the Trpa1 antisense probe produced a
specific staining in the DRG neurons (Fig. 4A). In gp130fl/fl sec-
tions, 23.1  4.4% of the neurons stained positively for Trpa1
mRNA, whereas SNS-gp130/ mice showed a significantly
lower percentage of Trpa1-positive neurons (7.5 1.4%;N
 3,
4–6 DRG per animal, sections/DRG; unpaired t test, t 

3.3577706, p 
 0.02836; Fig. 4B,C). These results support the
Figure 3. Neuronal gp130 was essential for Trpa1 mRNA expression in DRG. A, TaqMan mRNA analysis revealed significantly
lower Trpa1mRNA levels in DRG explants and primary neuronal cultures of SNS-gp130/mice (DRG from thoracic and lumbar
levels). B, Trpa1 mRNA expression was significantly reduced in lumbar DRG explants from SNS-gp130/ mice compared with
gp130fl/fl and SNS-Cre, which were not significantly different. Furthermore, Trpv1 and Trpv4 mRNA levels were similar between
gp130fl/fl and SNS-gp130/ mice. C, Trpa1 mRNA expression of lumbar DRG explants within the first 14 postnatal days. In
SNS-gp130/mice, Trpa1mRNA expressionwas already reduced at P1–P14. Expression levels are normalized to adult gp130fl/fl
mice. *p 0.05. **p 0.01. ***p 0.001.
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TaqMan qPCR data showing lower Trpa1mRNA expression lev-
els in SNS-gp130/DRGexplants comparedwith gp130fl/flmice.
As mentioned above, nociceptive neurons can generally be
classified into peptidergic andnonpeptidergic neurons. Although
previous studies report contrasting results about Trpa1 mRNA
expression in nonpeptidergic neurons, a recent study by Barabas
et al. (2012) suggests that TRPA1 function is primarily associated
with IB4-positive DRG neurons (Story et al., 2003; Bautista et al.,
2005; Obata et al., 2005; Caspani et al., 2009; Kim et al., 2010). To
assess the differential Trpa1 expression in nonpeptidergic versus
all DRG neurons, DRG sections were colabeled with AlexaFluor-
488-conjugated IB4. Because the dark blueNBT/BCIPprecipitate
can quench fluorescent dyes, HNPP/ FastRed TR was used as an
alternative substrate for the alkaline phosphatase for these exper-
iments. The percentage of IB4-positive neurons was unchanged
between gp130fl/fl and SNS-gp130/mice (gp130fl/fl: 34.2 3.3%
vs SNS-gp130/: 33.6 2.1%, 4–6 sections per animal, N
 5;
Fig. 5A–C), which is in accordance with our previous study (An-
dratsch et al., 2009). In gp130fl/fl lumbar DRG sections, 18.9 
3.6%of the neuronswereTrpa1-positive, whereas SNS-gp130/
mice revealed a significantly lower percentage of Trpa1-positive
neurons (8.3  1.7%; 4–6 sections per animal, N 
 5; Mann–
WhitneyU test, T
 39, p
 0.01587; Fig. 5D–F). A total of 40%
of the IB4-positive neurons expressed Trpa1mRNA in DRG sec-
tions from gp130fl/flmice. In SNS-gp130/mice, this percentage
was threefold lower (gp130fl/fl: 40.0  6.0% vs SNS-gp130/:
13.1  3.2%; Mann–Whitney U test, T 
 40, p 
 0.00794; Fig.
5G–I). On the other hand, only 5%–9% of IB4-negative DRG
neurons expressed Trpa1, and no significant difference in this
neuron population was detected between the two genotypes
(gp130fl/fl: 9.0  3.2% vs SNS-gp130/: 4.8  1.4%; Mann–
Whitney U test, T 
 34, p 
 0.22222). Together, these findings
support the hypothesis that the presence of gp130 is essential for
Trpa1 expression in IB4-positive nociceptive neurons.
Regulation of Trpa1mRNA expression via
JAK-STAT signaling
gp130-dependent cytokines signal via activation of the JAK-
STAT andMAP kinase pathway (Heinrich et al., 2003; Pellegrino
and Habecker, 2013). In primary cultures of DRG neurons, both
the JAK inhibitor I and the STAT inhibitor (Stattic) significantly
decreased Trpa1mRNA expression levels (JAK inhibitor I group:
control: 1.03902 0.1421 vs inhibitor: 0.33592 0.03694, T

57, p 
 0.00216; Stattic group: control: 1.01725  0.08066 vs
inhibitor: 0.63475  0.08534, T 
 54, p 
 0.01515; N 
 6; all
Mann–Whitney U test; Fig. 6). Expression levels of the house-
keeping genes Sdha, Gapdh, and 18S were similar in Stattic-
treated and control samples (N 
 2; data not shown). Our data
indicate that Trpa1mRNA expression is regulated by JAK-STAT
signaling pathways. Together with the reduced Trpa1mRNA ex-
pression in SNS-gp130/DRGneurons, this suggests that intact
gp130-JAK-STAT signal transduction is critically important for
Trpa1mRNA transcription.
Reduced responsiveness to TRPA1 agonists in SNS-gp130/
cultured sensory neurons
TRPA1 is a calcium-permeable ion channel that is activated by
numerous pungent substances. Mustard oil and CA are the most
commonly used activators of TRPA1 (Bandell et al., 2004; Jordt et
al., 2004; Macpherson et al., 2007). In gp130fl/fl cultures, 41.9%
(52 of 124,N
 3) of the neurons responded to a 90 s pulse of 200
M CA with a calcium transient, whereas a significantly smaller
proportion of neurons was activated by CA in SNS-gp130/
cultures (11.6%, 14 of 120,N
 3; 2
 26.80203with 1 degree of
freedom: p 
 0.0000002; Fig. 7A,B). At the same time, respon-
siveness to 0.3 M of the TRPV1 agonist capsaicin was similar in
gp130fl/fl and SNS-gp130/ cultures (gp130fl/fl: 43 of 124 neu-
rons
 34.6%vs SNS-gp130/: 39 of 110 neurons
 35.5%,N

3; Fig. 7A,B). This provides functional and translational evidence
supporting the differences in Trpa1 mRNA expression profiles
reported above.
Apart from CA, the chloride channel blocker NPPB has been
reported to selectively activate heterologously expressed TRPA1.
However, reports on sensory neurons are as yet not available for
this compound (Liu et al., 2010). NPPB caused a transient in-
crease in intracellular Ca2 concentration in cultured DRG neu-
rons obtained from control (TRPA1/) mice, but responses to
NPPBwere virtually absent in neurons obtained fromTRPA1/
mice (median ratio increase: TRPA1/: 0.12169 with 0.08273
and 0.16727 as lower and upper quartile, n 
 101, N 
 3;
TRPA1/: 0.23691 with 0.09383 and 0.7028 as lower and upper
quartile, n
 53, N
 2; Fig. 7C). This suggests that the calcium
transient observed was in response to NPPB exposure and was
indeed due to its agonistic action on TRPA1. Using NPPB as a
second TRPA1 agonist, we obtained a reduction of TRPA1 re-
sponsiveness in SNS-gp130/ DRG cultures, with a similar de-
gree to the one observed with CA. In gp130fl/fl cultures, 26.3% (31
of 118, N 
 3) of the neurons responded to NPPB with a mean
Figure 4. Reduced Trpa1mRNA levels in DRG sections of SNS-gp130/mice. A, ISH with
Trpa1 antisense riboprobe produced a selective staining of Trpa1-expressing neurons, whereas
sense probes did not show specific staining in the lumbar DRG sections. Scale bar, 50m. B,
Samples of gp130fl/fl and SNS-gp130/ lumbar DRG sections with Trpa1 antisense riboprobe
display reduced Trpa1mRNA labeling in SNS-gp130/ sections. Scale bar, 50m. C, Quanti-
fication of the ISH labeling in lumbar gp130fl/fl and SNS-gp130/ sections. SNS-gp130/
sections reveal significantly lower numbers of Trpa1 expressing neurons. *p 0.05.
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suprathreshold ratio increase of 1.52 
0.12 (Fig. 7D). However, only 10.8% (18
of 167, N
 4) of the SNS-gp130/ neu-
rons responded with a mean TRPA1-
mediated ratio increase of 1.11  0.11 to
the 60 s 100 MNPPB pulse. The propor-
tion and the magnitude of the TRPA1-
mediated ratio increase were significantly
lower than in control cultures (propor-
tion: 2
 10.59433 with 1 degree of free-
dom: p 
 0.00113; ratio increase:
unpaired t test: t 
 2.33996 with 47 de-
grees of freedom: p 
 0.02358; Fig. 7D).
Therefore, we conclude from these data,
with two different agonists, that the func-
tional expression of TRPA1 is reduced in
primary DRG cultures of SNS-gp130/
mice.
Attenuated nocifensive response to the
TRPA1 agonist CA in SNS-gp130/
mice in vivo
Finally, we assessed whether the downregu-
lation of TRPA1 expression in transgenic
gp130 mice was functionally relevant in
vivo. Injection of CA into the hindpaw of
control mice induced spontaneous nocif-
ensive behavior as reflected by a mean
licking duration of 25.9 8.4 s and mean
number of licking events of 7.3  1.6.
Control vehicle injection did not evoke nocifensive reactions
during the 5 min observation period (mean licking duration1
s; mean number of licking events 1; data not shown). SNS-
gp130/mice revealed a significantly attenuated response to the
TRPA1 agonist (licking duration: 7.0  4.0 s, T 
 75, p 

0.02890; licking events: 1.8  0.9, T 
 79, p 
 0.00591; Mann–
Whitney U test; N 
 7 or 8; Fig. 8). These data indicate that
downregulation of TRPA1 inmice with a null mutation of gp130
inNav1.8-expressing nociceptors is relevant for responsiveness to
noxious stimuli requiring TRPA1 in vivo. Overall, our data sug-
gest that gp130 in nociceptive neurons is an essential switch for
TRPA1 expression and absence of gp130 from nociceptive pri-
mary afferents causes severe deficits in acute mechanonocice-
ption and nocifensive reactions to TRPA1 agonists.
Discussion
In the present study, we addressed the importance of neuronally
expressed gp130 for mechanonociception, using a conditional
transgenic gp130 knock-out mouse model previously generated
in our group (Andratsch et al., 2009; Quarta et al., 2011). In behav-
ioral tests and electrophysiological recordings, SNS-gp130/mice
revealed reducedmechanonociception comparedwith controlmice
(Fig. 1). This deficit in mechanonociception was accompanied by
low Trpa1mRNA expression levels, predominantly in nonpepti-
dergic neurons of SNS-gp130/ mice from early postnatal de-
velopment onwards (Figs. 234-5). Downstream of gp130, JAK
and STAT were involved in the regulation of Trpa1 transcription
(Fig. 6), and the reduction in Trpa1 expression in SNS-gp130/
mice was associated with functional deficits in vitro and in vivo
(Figs. 7 and 8).
Cytokines of the IL-6 family use a combination of ligand bind-
ing -receptors (IL-6R, IL-11R, and CNTFR) and the signal
transducing receptor subunits gp130, LIFR, and OSMR. Com-
mon to all these receptor combinations is the essential require-
ment of at least one gp130 subunit for signal transduction. After
activation, gp130 acts via classical JAK-STAT signaling and
activation of the mitogen-activated protein kinase (MAPK)
pathway (for review, see Heinrich et al., 2003). In addition to
transcriptional regulation, IL-6 has been shown to enhance cap-
dependent translation by mediating eIF4F cap complex forma-
tion, a process that allows control of translation in DRG neurons
and is relevant for mechanical allodynia (Melemedjian et al.,
Figure5. Trpa1deficiencywas predominantly observed in IB4-bindingnociceptive neurons.A,B, Staining for IB4neurons in
gp130fl/fl and SNS-gp130/ DRG sections. Scale bar, 50 m. C, The percentage of IB4-binding neurons was similar in both
genotypes. D, E, FISH for Trpa1mRNA in gp130fl/fl and SNS-gp130/ DRG sections. Scale bar, 50m. F, Quantification of FISH
shows that the number of Trpa1 mRNA-expressing neurons (Trpa1) was significantly reduced in SNS-gp130/ mice. G, H,
Colabeling of Trpa1 mRNA expressing (magenta) and IB4-binding (green) neurons in both genotypes. Scale bar, 50 m. I, In
control mice, Trpa1mRNAwas predominantly expressed in IB4-positive neurons. In SNS-gp130/mice, reduction of Trpa1was
most noticeable in the IB4-positive population. n.s., Not significant ( p 0.05). *p 0.05. **p 0.01.
Figure 6. Expression of Trpa1 mRNA was controlled by the JAK-STAT pathway. TaqMan
mRNAanalysis revealed significantly reduced Trpa1 expression levels in DRGneurons incubated
witha selective JAK inhibitor I (JAKI, 1M)or a STAT inhibitor,with selectivity for STAT3 (Stattic,
1.5M). *p 0.05. **p 0.01.
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2010). Here, we present strong evidence that regulation of
TRPA1 by gp130 primarily takes place on the transcriptional level
because (1) Trpa1 mRNA expression was reduced in SNS-
gp130/ compared with control mice (Figs. 2 and 3); (2) the
percentage of Trpa1 mRNA-expressing neurons was lower in
SNS-gp130/ than in controlmice (Figs. 4 and 5); and (3)Trpa1
mRNA expression was significantly downregulated by experi-
mental inhibition of the JAK-STAT pathway (Fig. 6).
Regulation of TRPA1 so far has been predominantly studied
on the level of ion-channel modification (for review, see Nilius et
al., 2012); however, only a few factors are known to influence
Trpa1 mRNA expression. The proinflammatory cytokines
TNF- and IL-1 activate the transcription factors NF-B and
HIF-1a, which increase Trpa1 mRNA expression (Hatano et al.,
2012). Further support for a cytokine-based regulation of Trpa1
comes from a transgenic IL-13 mouse model for atopic dermati-
tis, in which Trpa1 expression is increased in mast cells, DRG
neurons, and nerve fibers innervating the skin (Oh et al., 2013).
In DRG neurons, previous studies mainly investigated differen-
tial Trpa1 expression after inflammation (Obata et al., 2005;
Schwartz et al., 2011; Merrill et al., 2012) and during late embry-
onic and postnatal development (Hjerling-Leffler et al., 2007;
Abdel Samad et al., 2010; Gascon et al., 2010; Franck et al., 2011).
After inflammation and spinal nerve ligation, NGF increases
Trpa1 mRNA expression in DRG neurons via p38 (Obata et al.,
2005; Diogenes et al., 2007). During development, the signaling
receptor for GDNF family ligand Ret is required for Trpa1 ex-
pression and the development of nonpeptidergic DRG neurons
(Luo et al., 2007; Abdel Samad et al., 2010; Franck et al., 2011).
However, Ret also regulates Trpa1 expression in adulthood, and
Trpa1mRNA levels are increased by overexpression of theGDNF
family ligand artemin, but not by injection ofGDNF (Obata et al.,
2005; Elitt et al., 2006; Franck et al., 2011).
Apart from their crucial role in inflammation and regenera-
tion, cytokines of the IL-6 family are important survival and dif-
ferentiation factors for neurons (Murphy et al., 1991, 1993;
Thompson et al., 1996; Banner et al., 1998; Nakashima et al.,
1999; Zhong et al., 1999). Our results indicate a new role for
IL-6-related cytokines, inwhich gp130 determines the expression
of TRPA1, most likely via the JAK-STAT pathway. Our model of
gp130-depedent ion channel expression in nociceptive neurons is
backed up by studies investigating the role of OSM in DRG neu-
rons where OSM is essential for the development of a subpopu-
lation of TRPV1/P2X3-expressing neurons (Morikawa et al.,
2004). The OSM receptor  is predominantly expressed in non-
peptidergic neurons, and its expression starts around postnatal
day 0 before it reaches adult expression levels at P14 (Tamura et
al., 2003; Morikawa et al., 2004). OSM/ mice do not only
reveal attenuated reactions to the injection of TRPV1 and P2X3
agonists, but also to formalin injection and in the tail-clip test for
mechanical sensitivity. Because formalin is a direct agonist for the
mechanosensitive channel TRPA1 (McNamara et al., 2007), this
test can also be interpreted as an indicator for a differential ex-
pression of TRPA1 in OSM/ mice, which so far has not been
investigated. In line with these results, we observed that gp130
was especially necessary for Trpa1 expression in nonpeptidergic
IB4-binding neurons (Fig. 5) and that the ablation of gp130 af-
fected Trpa1 expression already during early postnatal develop-
ment (Fig. 3). In contrast to the study of Morikawa et al. (2004),
we detected neither a change in Trpv1 mRNA expression levels
(Fig. 3) nor in the percentage of TRPV1-expressing neurons in
SNS-gp130/ mice (Fig. 7). This difference can easily be ex-
plained by the nature of the twomouse strains. In SNS-gp130/
Figure 8. Attenuated CA-induced nocifensive behavior in SNS-gp130/ mice. SNS-
gp130/mice displayed a significantly shorter licking duration and reduced number of licks
of their hindpaws in response to an injection of 20 l 1% CA during the 5 min observation
period. *p 0.05. **p 0.01.
Figure 7. Functional TRPA1 expression was reduced in cultured primary DRG neurons of
SNS-gp130/mice.A, Calcium imaging sample tracesof primaryneurons stimulatedwith the
TRPA1-agonist CA (200M), highpotassiumchloride (KCl, 25mM) and TRPV1-agonist capsaicin
(0.3M). B, The percentage of neurons responding to CA was significantly decreased in SNS-
gp130/ cultures. In contrast, the responsiveness to capsaicin (Caps) was unchanged. C,
Calcium imaging sample traces of primary neurons stimulatedwith NPPB (100M) and KCl (25
mM). Responses to NPPB were greatly diminished in TRPA1/ neurons. Magnitude of ratio
increase in response to stimulation with 100 M NPPB in TRPA1/ (n
 53, N
 2) and
TRPA1/ (n
 101, N
 3) neuronal cultures. The highest ratio increase in TRPA1/
cultures was considered as threshold for TRPA1-mediated responses to NPPB. TRPA1/ and
TRPA1/: boxes represent median as well as lower and upper quartile; whiskers represent
the 10th and 90th percentiles.D, Percentage and ratio increase of neurons responding to NPPB
with a suprathreshold ratio increase in gp130fl/fl and SNS-gp130/ neuron cultures. In SNS-
gp130/ cultures, the number of neurons responding to NPPB was significantly decreased,
and NPPB-responsive cells showed a significantly lower ratio increase to the stimulus. *p
0.05. **p 0.01. ***p 0.001.
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mice, gp130 ablation is effective in 90% of the Nav1.8-expressing
DRG neuron population (Andratsch et al., 2009). Hence, a resid-
ual population of nociceptive neurons still maintains gp130 sig-
naling. Furthermore, functional TRPV1 expression emerges on
embryonic day E12.5 and thus precedes Nav1.8 and Cre-
recombinase expression, which becomes detectable around P0
and coincides with TRPA1 expression (Agarwal et al., 2004;
Hjerling-Leffler et al., 2007). However, in OSM/ mice with a
global null mutation of OSM, it cannot be excluded that non-
neuronal cell types contribute to the phenotype observed. More
importantly, OSM effects can be conveyed via both OSMR--
gp130 and LIFR-gp130 heteromeric receptor complexes. The lat-
ter can regulate specific populations of sensory neurons during
embryonic development (Murphy et al., 1997), whereas TRPV1-
expressing populations are very likely established before gp130
depletion in SNS-gp130/mice.
Although different mechanisms, including mechanically acti-
vated ion channels, have been proposed for force transduction in
nociceptive neurons, the molecular mechanisms of mechanono-
ciception are still largely enigmatic (Lumpkin andCaterina, 2007;
Delmas et al., 2011;Delmas andCoste, 2013).We have previously
shown that cultured SNS-gp130/ DRG neurons demonstrate
reduced excitability compared with control mice, which is based
on increased delayed rectifier and A-type potassium currents
with no observable changes in voltage-gated sodium and calcium
currents. Moreover, this is accompanied by increased expression
of A-type channel Kcna4, but not Kcnh1 (Langeslag et al., 2014).
Although Kcna4 has not been associated with mechanonocicep-
tion, reduced excitability of nociceptive fibers could lead to a
hyponociceptive phenotype. However, our previous studies do
not reveal reduced sensitivity of SNS-gp130/mice to heat stim-
ulation under basal conditions (Andratsch et al., 2009; Langeslag
et al., 2011). Therefore, the reduced excitability would have to be
restricted tomechanosensitive C-fibers, a theory for which we do
not have any indication. Alternatively to a reduced neuronal ex-
citability, we present here with the decreased expression of
TRPA1 a further possible mechanism for the deficit in mecha-
nonociception of SNS-gp130/mice. Among several other can-
didate ion channels, TRPA1 has evolved as an important
transducer for noxious mechanical stimuli. TRPA1 can be acti-
vated by mechanical stimulation of DRG neurons, and a null
mutation of TRPA1 affects intermediate or slowly adapting
mechanosensitive ionic currents in small-diameterDRGneurons
(Vilceanu and Stucky, 2010; Brierley et al., 2011). Furthermore,
this effect can be rescued by reintroduction of TRPA1 into DRG
neurons of TRPA1 knock-out mice (Brierley et al., 2011). Al-
though controversial results have been published, themajority of
studies show that deletion and pharmacological inhibition of
TRPA1 reduce the responsiveness of nociceptors to mechanical
forces in electrophysiological recordings of single-nerve fibers
and in assays of mechanosensitivity in vivo (Bautista et al., 2006;
Kwan et al., 2006, 2009; Petrus et al., 2007). The reduced mecha-
nosensitivity of SNS-gp130/ mice in the present study bears
great resemblance to the previously published phenotype ob-
served in TRPA1/mice. In particular, both transgenic mouse
strains reveal deficits in the detection of strongmechanical forces
(Kwan et al., 2006).
Together, we propose a model in which the presence of gp130
in small DRG neurons is critically important for mechanonoci-
ception and control of TRPA1 expression in nonpeptidergic neu-
rons. Our data shed new light on the importance of IL-6-related
cytokines for the development and functional properties of the
nociceptive system. Despite conflicting results, numerous studies
indicate that pharmacological inhibition of TRPA1 attenuates
mechanical hypersensitivity originating from inflammation,
nerve injury, or chemotherapy-induced neuropathy (Obata et al.,
2005; Bautista et al., 2006; Dai et al., 2007; Petrus et al., 2007; Eid
et al., 2008; Brierley et al., 2011; Nassini et al., 2011). Neuropoi-
etic IL-6 is a keymediator in innate immunity, inflammation, and
mechanical hypersensitivity in different models for chronic pain
(Brenn et al., 2007; Quarta et al., 2011). The present study stresses
the importance of the IL-6 signal transducer gp130 in nociceptor
responsiveness. Rather than gp130 causing direct sensitization,
we suggest that it acts in nociceptors as general switch for the
expression of TRPA1, as one critically important ion channel for
mechanonociception.
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